AR
About
Education
Library
MEMBERSHIP
Business
Blog
login
Register Now
login
Register
Now
×
Log in
Remember me
Viewing 1097 results
Library Categories
ALL
Research & Ethics
Soft Skills
Medicine & Surgery
Pediatric
Internal Medicine
Neurology
ICU
General Surgery
ENT
Dermatology
Emergency
Family Medicine
OB & GYN
Psychiatry
General
Orthopedics
Radiology
Oncology
Diabetes
Rheumatology
Public Health
Allied Medical Sciences
MLT
Respiratory therapy
Physical therapy
Rehabilitation
Nursing
Pharmacy
Health Informatics
Health administration
Medical Education
E-Nutrition Hub
Oncology
Jaypirca: A Novel BTK Inhibitor With a Well-Tolerated Safety Profile
By :
Dr.Chaves
Oncology
How Does Jaypirca Work? The Science Explained
By :
Dr Alan Skarbnik
Diabetes
Supporting Patients with Obesity Through Comprehensive Treatment
By :
Prof.W.Timothy Garvey
Diabetes
Proposed actions of GIP and GLP1 receptor agonist in human
By :
Prof.Rachel Batterham
Diabetes
Potential Impact of Weight Reduction on Obesity-Related Complications
By :
Prof.W.Timothy Garvey
Oncology
Sparking discussions on Jaypirca – Efficacy results
By :
Dr Julio Chavez
Oncology
Sparking Discussions about Jaypirca Appropriate Patients
By :
Dr Alan Skarbnik
Oncology
Jaypirca, the first and only reversable BTK inhibitor
By :
Dr.John M Pagel
Medical Education
Writing and Assessing NCAAA Compatible Learning Outcomes
By :
Dr. Shoroog Agou
Dermatology
The efficacy of Olumiant in children and adolescents with moderate to severe atopic dermatitis.
By :
Prof. Antonio Torrelo
Dermatology
The burden of disease and unmet treatment needs in children and adolescents with moderate to severe atopic dermatitis
By :
Prof. Antonio Torrelo
Dermatology
Prescribing Olumiant for your pediatric patients: practicalities, safety profile and flexible dosing
By :
Prof. Antonio Torrelo
Show More